The aims of this proposal concern studies aimed at a better understanding of virus persistence, latency and reactivation and their role in virus oncogenesis. A multidisciplinary approach involves scientists with expertise in cell biology, virology, immunology, molecular biology, genetics, oncology, and pathology. Focus of the program is on human herpesviruses and human papillomaviruses although other viruses will also serve as model system when indicated. The studies proposed will examine molecular events involved in latency and reactivation of herpes simplex virus, including gene sequences and products able to activate virus replication and properties of cells and virus restricting virus replication. These phenomenon may be critical in maintenance of the latent state, which may be a prelude to transformation. The immune response to virus infection and to tumor cells will be dissected to determine events at the molecular level that enable escape from immune surveillance, clearly important for progression to malignancy. Chronic virus infections, often in the presence of an immune responce, represent a major hurdle in control of infectious disease. Herpes simplex virus latency, long the prototype of such a condition, is now known to be only one of many viruses that can remain laten in the human host. The immune deficiency virus represents another major group that can persist for an extended period of time following infection and it is possible that many chronic degenerative central nervous system disorders (i.e., multiple sclerosis, Alzheimer's disease) have a virus component as a causal factor. Hence, information obtained in this program may well be relevant to the general problem of control of chronic virus infections.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA027503-12
Application #
3093199
Study Section
Cancer Special Program Advisory Committee (CAK)
Project Start
1980-04-01
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
12
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Pennsylvania State University
Department
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Peng, X; Lang, C M; Kreider, J W (1996) Immortalization of inbred rabbit keratinocytes from a Shope papilloma and tumorigenic transformation of the cells by EJ-ras. Cancer Lett 108:101-9
Peng, X; Lang, C M; Kreider, J W (1995) Methylation of cottontail rabbit papillomavirus DNA and tissue-specific expression in transgenic rabbits. Virus Res 35:101-8
Kenny, J J; Krebs, F C; Hartle, H T et al. (1994) Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter. Virology 200:220-35
Samaniego, L A; Tevethia, M J; Spector, D J (1994) The human cytomegalovirus 86-kilodalton immediate-early 2 protein: synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin. J Virol 68:720-9
Spector, D J; Tevethia, M J (1994) Protein-protein interactions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J Virol 68:7549-53
Kierstead, T D; Tevethia, M J (1993) Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J Virol 67:1817-29
Peng, X; Olson, R O; Christian, C B et al. (1993) Papillomas and carcinomas in transgenic rabbits carrying EJ-ras DNA and cottontail rabbit papillomavirus DNA. J Virol 67:1698-701
Wisotzkey, J D; Krizenoskas, A; DiAngelo, S et al. (1993) Cleavage of cottontail rabbit papillomavirus E7 RNA with an anti-E7 ribozyme. Biochem Biophys Res Commun 192:833-9
Okabayashi, M; Pickel, M D; Budgeon, L R et al. (1993) Podofilox-induced regression of Shope papillomas may be independent of host immunity. J Invest Dermatol 101:852-7
Bonneau, R H; Salvucci, L A; Johnson, D C et al. (1993) Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Virology 195:62-70

Showing the most recent 10 out of 61 publications